Phase 1/1b Multiple-Ascending Dose Study of DF6215 in Patients With Advanced Solid Tumors

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507320-23-00

Acronym

DF6215-001

Enrollment

Registered

2024-04-05

Start date

2024-04-26

Completion date

2025-09-08

Last updated

2025-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Solid Tumors

None listed

Sex/Gender

All

Age

18 Years to No maximum

France

None listed

Source: EU CTIS · Data processed: Feb 4, 2026